Investors tracking the latest maneuvers of Cathie Wood’s ARK ETFs will note the mix of strategic buys and sells for Wednesday, 23 April 2025. Leading the trades was a significant investment in AEROVIRONMENT INC (NASDAQ:AVAV), with ARK purchasing 11,682 shares amounting to a robust $1,754,402. On the flip side, the largest sale involved KRATOS DEFENSE AND SECURITY SOLUTIONS INC (NASDAQ:KTOS), with 84,963 shares sold, totaling $2,729,011.
Cathie Wood’s ARK ETF published their daily trades for Wednesday, April 23rd, 2025, revealing a series of calculated adjustments to their portfolio. The trades reflected a diverse approach to investment, with both acquisitions and divestitures across various sectors.
In a notable move, ARK increased its stake in IRIDIUM COMMUNICATIONS INC (NASDAQ:IRDM), buying a combined 204,363 shares across three of its funds, ARKK, ARKQ, and ARKX (NYSE:ARKX), for a total value of $4,416,284. This purchase is part of a growing trend, as ARK has been consistently adding to its IRIDIUM holdings in recent days.
Another significant buy was in NURIX THERAPEUTICS INC (NASDAQ:NRIX), with 104,048 shares acquired for $1,192,390. This follows a pattern of smaller, yet steady purchases of NURIX stock over the past week, suggesting a bullish outlook on the biotech company.
On the sell side, ARK continued to reduce its position in ADAPTIVE BIOTECHNOLOGIES CORP (NASDAQ:ADPT), offloading 147,820 shares through its ARKG ETF, resulting in proceeds of $1,036,218. This sale is part of a larger divestiture from ADAPTIVE BIOTECHNOLOGIES, as ARK has been selling its shares consistently over the last few trading sessions.
Other sales included a minor reduction in MICROSOFT CORP (NASDAQ:MSFT), with 182 shares sold for $66,761, and a more substantial sell-off of UIPATH INC (NYSE:PATH), parting with 48,288 shares across two ETFs, ARKW and ARKF, for a total of $505,575.
Smaller transactions rounded out the day’s activity. ARK bolstered its holdings in ADVANCED MICRO DEVICES INC (NASDAQ:AMD), AMGEN INC (NASDAQ:AMGN), BEAM THERAPEUTICS INC (NASDAQ:BEAM), NVIDIA CORP (NASDAQ:NVDA), and 10X GENOMICS INC (NASDAQ:TXG), with respective purchases reflecting a continued interest in the tech and biotech sectors. Conversely, minor sales were executed in ROBLOX CORP (NYSE:RBLX), VERACYTE INC (NASDAQ:VCYT), and an almost negligible sale of REPARE THERAPEUTICS INC (NASDAQ:RPTX), indicating a trimming of positions rather than a strategic exit.
Investors monitoring ARK’s trades can discern a pattern of reinforcing positions in companies poised for growth while strategically divesting from others, a tactic that has become a signature of Cathie Wood’s investment style.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.